Cargando…
Re: COVID-19 in patients with neuroendocrine neoplasms: Preliminary results of a worldwide survey (The INTENSIVE study)
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8387225/ https://www.ncbi.nlm.nih.gov/pubmed/34507831 http://dx.doi.org/10.1016/j.ejca.2021.07.046 |
_version_ | 1783742418404769792 |
---|---|
author | Takada, Kazuki Takamori, Shinkichi Miura, Naoko Shikada, Yasunori Shimokawa, Mototsugu |
author_facet | Takada, Kazuki Takamori, Shinkichi Miura, Naoko Shikada, Yasunori Shimokawa, Mototsugu |
author_sort | Takada, Kazuki |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-8387225 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Elsevier Ltd. |
record_format | MEDLINE/PubMed |
spelling | pubmed-83872252021-08-26 Re: COVID-19 in patients with neuroendocrine neoplasms: Preliminary results of a worldwide survey (The INTENSIVE study) Takada, Kazuki Takamori, Shinkichi Miura, Naoko Shikada, Yasunori Shimokawa, Mototsugu Eur J Cancer Letter to the Editor Elsevier Ltd. 2021-11 2021-08-26 /pmc/articles/PMC8387225/ /pubmed/34507831 http://dx.doi.org/10.1016/j.ejca.2021.07.046 Text en © 2021 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Letter to the Editor Takada, Kazuki Takamori, Shinkichi Miura, Naoko Shikada, Yasunori Shimokawa, Mototsugu Re: COVID-19 in patients with neuroendocrine neoplasms: Preliminary results of a worldwide survey (The INTENSIVE study) |
title | Re: COVID-19 in patients with neuroendocrine neoplasms: Preliminary results of a worldwide survey (The INTENSIVE study) |
title_full | Re: COVID-19 in patients with neuroendocrine neoplasms: Preliminary results of a worldwide survey (The INTENSIVE study) |
title_fullStr | Re: COVID-19 in patients with neuroendocrine neoplasms: Preliminary results of a worldwide survey (The INTENSIVE study) |
title_full_unstemmed | Re: COVID-19 in patients with neuroendocrine neoplasms: Preliminary results of a worldwide survey (The INTENSIVE study) |
title_short | Re: COVID-19 in patients with neuroendocrine neoplasms: Preliminary results of a worldwide survey (The INTENSIVE study) |
title_sort | re: covid-19 in patients with neuroendocrine neoplasms: preliminary results of a worldwide survey (the intensive study) |
topic | Letter to the Editor |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8387225/ https://www.ncbi.nlm.nih.gov/pubmed/34507831 http://dx.doi.org/10.1016/j.ejca.2021.07.046 |
work_keys_str_mv | AT takadakazuki recovid19inpatientswithneuroendocrineneoplasmspreliminaryresultsofaworldwidesurveytheintensivestudy AT takamorishinkichi recovid19inpatientswithneuroendocrineneoplasmspreliminaryresultsofaworldwidesurveytheintensivestudy AT miuranaoko recovid19inpatientswithneuroendocrineneoplasmspreliminaryresultsofaworldwidesurveytheintensivestudy AT shikadayasunori recovid19inpatientswithneuroendocrineneoplasmspreliminaryresultsofaworldwidesurveytheintensivestudy AT shimokawamototsugu recovid19inpatientswithneuroendocrineneoplasmspreliminaryresultsofaworldwidesurveytheintensivestudy |